Contrary to popular belief, Francis Mojica was the first person to discover the CRISPR mechanism and give it its name. He told me how the discovery came about, discussed the wide potential of the gene editing tool and shared his favorite CRISPR application.| Labiotech.eu
Discover the best in biotech: companies, influential individuals, locations, and more! Explore our curated lists of excellence in the biotech world.| Labiotech.eu
uniQure, Dianthus Therapeutics, and Mineralys Therapeutics bagged the biggest biotech funding rounds overall in September 2025. The post The biggest biotech funding rounds in September 2025 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiot...| Labiotech.eu
This week, we discussed funding with Gerard Caelles, Chief Business Office of Splice Bio, a company that just closed a $135 million series B round. The post Raising money in uncertain times: how Splice Bio secured $135 million for its gene therapy play appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may ...| Labiotech.eu
Merck’s decision to back out of its $1 billion expansion comes as U.K. investments in life sciences declines. The post Merck backs out of Britain: is the U.K. struggling to retain its life sciences sector? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credi...| Labiotech.eu
Find out about this new study that suggest that the lung scarring that severe asthma can cause could be reversible. The post Asthma study suggests lung scarring may be reversible appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG an...| Labiotech.eu
Driven by CASGEVY's success, the CRISPR field is experiencing substantial growth with a new wave of companies. The post CRISPR technology’s next wave: Ten companies to watch in 2025 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech ...| Labiotech.eu
FDA approval for Stealth BioTherapeutics' elamipretide has been a long time coming. What does this mean for other ultra-rare disease companies? The post First-ever approval for Barth Syndrome treatment: what does this mean for ultra-rare disease therapeutics? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and l...| Labiotech.eu
BIOSPAIN 2025 returns to Barcelona, bringing 2,200+ biotech professionals for networking, collaborations, and industry insights. The post Destination BIOSPAIN 2025: What you need to know about Spain’s flagship event for biotech appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that ...| Labiotech.eu
Animal testing is crucial for measuring the efficacy and safety of new treatments. It is also a step that everyone would like to avoid as much as possible for economic, regulatory, and ethical reasons. But what are the alternatives, and can they really reduce the use of animals in drug development? Before drug developers let […] The post Can biotechnology reduce animal testing in medicine? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplicatio...| Labiotech.eu
This week's guest is Joseph Ferner of Inpart, the author of a new R&D Trends Report on Immunology and Inflammation. Together we discussed the research landscape The post What’s next in immunology & inflammation R&D: The trends to watch appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provid...| Labiotech.eu
Colossal Biosciences has just had a major breakthrough in its attempt to revive the dodo bird. What are the ethical concerns? The post Resurrecting the dodo: an ethical dilemma or chance at restoring biodiversity? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear...| Labiotech.eu
Delve into a biopharma giant's strategy, Eli Lilly. This past year, the company secured regulatory milestones and strategic deals. The post Eli Lilly’s strategy in motion: Beyond diabetes and obesity appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is ...| Labiotech.eu
The German biotech ecosystem is well established despite the challenges it is facing. Discover fourteen key Germany-based biotech companies.| Labiotech.eu
Get the latest biotech news for Precision medicine, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Get the latest biotech news for Drug discovery, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Labiotech works with life sciences companies to create impactful brand awareness and lead gen campaigns. Discover our portfolio of sponsored articles below!| Labiotech.eu
Stay informed on the latest worldwide biotech news and trends. Learn more about groundbreaking discoveries, partnerships, funding, and more.| Labiotech.eu
As the release of a CRL declining Lykos' therapy generates a strong reaction from MAPS, delve into what this new transparency could change.| Labiotech.eu
Get the latest news on the applications of Artificial Intelligence (AI) and machine learning in drug discovery, healthcare, agriculture, and more.| Labiotech.eu
The past year saw pipeline cuts and downsizing plans strike the biotech industry. Does the biotech job market seem to be looking up this year?| Labiotech.eu
As the biotech industry flourishes, drug developers need to interact increasingly with patient organizations, especially in the rare disease space.| Labiotech.eu
Unlock exclusive career opportunities in biotech and biopharma with our curated list of top life sciences job boards.| Labiotech.eu
Biotech startups are a high-risk venture. Experts explain what the most common reasons for failure are and what can be done to avoid them.| Labiotech.eu
Funding a biotech startup can be challenging. Delve into our guide to navigate this complicated investment landscape.| Labiotech.eu
Mission statement, purpose and vision are essential to the success of a biotech. Delve into the stategies to build on company culture.| Labiotech.eu
By Varvara Melikhova, founder and CEO of Unison Innovations Strategic partnerships are a better way to build a product’s capabilities than outright acquisitions. While the M&A path is set out for the most mature successful startups, early-stage partnerships can enhance a product’s market value and provide access to Big Pharma expertise and infrastructure, which significantly […]| Labiotech.eu
The last month has seen several big investments in European neuromodulation and neurostimulation companies, which aim to treat neurological conditions by zapping nerve cells. What's the reason for this funding peak?| Labiotech.eu
Since the Hormone Replacement Therapy market was destroyed almost overnight in 2002, there has been a lot of caution about investing in companies with a focus on women’s health. Mary Kerr, CEO of KaNDy Therapeutics and NeRRe Therapeutics, knows this only too well, but has not let it deter her in her quest to bring a treatment for symptoms of the menopause to the market.| Labiotech.eu
Many biotech entrepreneurs dread the possibility of investors taking control in a situation that resembles a hostile takeover. But it needn't be that way.| Labiotech.eu
Building a biotech startup can be a daunting task and often founders rely on incubators - but how to choose the right one?| Labiotech.eu
Sabine Dandiguian, Managing Partner at the life sciences VC firm Jeito Capital, shares her experience building a thriving company culture.| Labiotech.eu
What's my business model? Who do I partner with? How do I scale up? These are typical strategic questions a young biotech will regularly face.| Labiotech.eu
Explore our articles offering advice and consulting on various aspects of the biotech industry, from strategic planning to market analysis and partnerships.| Labiotech.eu
To honor International Women's Day, we asked female biotech leaders for their tips on how to encourage women in the life sciences industry.| Labiotech.eu
Get the latest biotech news for Europe, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Hiring is a big challenge in biotech; life sciences recruitment experts share their strategies for attracting and retaining talent in the biotech industry.| Labiotech.eu
As new measures are being developed to spur quicker and efficient diagnoses, here are six molecular diagnostics companies to look out for.| Labiotech.eu
Here is a list of 14 biotech podcasts to keep you up to date with the latest advances in the biotechnology industry.| Labiotech.eu
Here’s a list of the 15 public European biotech companies that are worth more than a billion euros in 2022.| Labiotech.eu
To commemorate Lupus Awareness Month in May, here are five advancements in lupus research over the past year.| Labiotech.eu
As we celebrate International Women’s Day, here are 5 women who are leading the way in research and innovation in the biotech industry!| Labiotech.eu
Discover how melanoma vaccines are gaining traction in the clinic and could soon become a treatment option for this deadly skin cancer.| Labiotech.eu
The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024.| Labiotech.eu
The companies Treeline Biosciences, Kailera Therapeutics, and Seaport Therapeutics bagged the biggest private biotech investments in October 2024.| Labiotech.eu
The companies Uniquity Bio, AltruBio, and BridgeBio Oncology Therapeutics bagged the biggest private biotech investments in May 2024.| Labiotech.eu
The companies Formation Bio, Isotopen Technologien München, and Marea Therapeutics bagged the biggest private biotech investments in June 2024.| Labiotech.eu
The companies Xaira Therapeutics, Metsera, and Obsidian Therapeutics bagged the biggest private biotech investments in April 2024.| Labiotech.eu
Discover why some biotechs fail but survive with cash on hand, and how players like Concentra are trying to unlock trapped capital.| Labiotech.eu
Abivax, MapLight Therapeutics, Everest Medicines, and Soleno Therapeutics bagged the biggest biotech funding rounds overall in July 2025.| Labiotech.eu
New narcolepsy treatments are being tested in the clinic, and recently, some of them have made promising strides. How far along are they?| Labiotech.eu
Discover Denmark's dynamic biotech scene with 10 innovative companies at the forefront of the biopharmaceutical revolution!| Labiotech.eu
Learn how Deep Science Ventures’ zero-data approach tackles biotech’s early funding challenges to speed innovation and reduce risk.| Labiotech.eu
NATO Innovation Fund backs Portal Biotech in its first biotech move. What does this signal for strategic investment in healthcare innovation?| Labiotech.eu
XOMA Royalty’s acquisition of Turnstone Biologics highlights how royalty deals can revive biopharma companies and drive industry innovation.| Labiotech.eu
Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News!| Labiotech.eu
From groundbreaking immunotherapies to AI diagnostics and new vaccines, explore the innovations shaping the future of cancer treatment.| Labiotech.eu
Australia's bet is to keep its biotech landscape innovative throught R&D tax incentives. Delve into their strategy and its results.| Labiotech.eu
Read more to find out what role ChatGPT has to play in the drug discovery process within the life sciences industry.| Labiotech.eu
A spate of royalty deals are changing the way certain biotechs press ahead, as seen with Cytokinetics’ agreement with Royalty Pharma.| Labiotech.eu
Plastic is the staple material of modern life, and a sustainable future will need bioplastics. What is Biotech doing to make this happen?| Labiotech.eu
Explore the intricate world of the biotech industry, delving deep into current trends and challenges through our collection of in-depth analysis articles.| Labiotech.eu
Find out how CAR-T cell therapy, which has been so groundbreaking in treating blood cancers, could potentially cure glioblastoma.| Labiotech.eu
Get the latest biotech news for Career, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Discover expert advice from recruiters on crafting a standout biotech resume that grabs employers' attention and lands you interviews.| Labiotech.eu
Check out five important biotechnology careers that are currently in high demand, and likely still will be in the coming years.| Labiotech.eu
Building a career in biotech can be a daunting task without the right skills. Delve into the strategies to improve and leverage them.| Labiotech.eu
Alan Levy shares his experience on how to make the relationship between the board and the CEO of a life sciences company work.| Labiotech.eu
Find the top upcoming international biotech conferences, events, seminars, webinars, and workshops for 2024!| Labiotech.eu
Here is a list of ten recruiters in the biotech space, nominated by our readers, who are making strides in the life science sector.| Labiotech.eu
The companies Metsera, Alentis Therapeutics, and Adcendo bagged the biggest private biotech investments in November 2024.| Labiotech.eu
The companies Cardurion Pharmaceuticals, Beacon Therapeutics, and Third Arc Bio bagged the biggest private biotech investments in July 2024.| Labiotech.eu
The companies Borealis Biosciences, Outpace Bio, and Halda Therapeutics bagged the biggest private biotech investments in August 2024.| Labiotech.eu
The companies Immunovant, Verdiva Bio, and Akero Therapeutics bagged the biggest biotech funding rounds overall in January 2025.| Labiotech.eu
Get the latest biotech news for USA, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Get the latest biotech news for United Kingdom, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Get the latest biotech news for China, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Those are our privacy policies, showing you how we respect your privacy and your data, so we all live in a happy and non-spammy world :)| Labiotech.eu
The month of December 2024 saw a variety of biotech deals take place to advance therapies across different stages in development.| Labiotech.eu
The companies Nuvig Therapeutics, Ottimo Pharma, and Angitia Biopharmaceuticals bagged the biggest private biotech investments in December 2024.| Labiotech.eu
GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.| Labiotech.eu
The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease?| Labiotech.eu
In this article, we take a look at eight biotechs that have acquired funding in recent years to fortify their GPCR-focused pipelines.| Labiotech.eu
Take a look at six multiple sclerosis companies trying to make a difference to patients by advancing new treatments for the CNS disease.| Labiotech.eu
Here are eight nanotechnology companies that are widening the scope in medicine, that you should know about.| Labiotech.eu
Find out more about six biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human health.| Labiotech.eu
Stay informed about the latest clinical trial news, inlcuding the outcomes of ongoing clinical trials, new innovative trial methodologies, and more!| Labiotech.eu
Eisai and Biogen have announced that the FDA has approved LEQEMBI 100 mg/mL injection for intravenous use for treating Alzheimer's disease.| Labiotech.eu
Get the latest news related to Alzheimer's, including the latest research, partnerships, and technology advancements of alzheimer's biotech companies.| Labiotech.eu
Learn more about Biogen's strategic realignment from Aduhelm's controversy to Leqembi's promise in Alzheimer's treatment.| Labiotech.eu
As we observe Alzheimer's & Brain Awareness Month in June, here are six recent advancements that could transform Alzheimer's research.| Labiotech.eu
Get the latest biotech news for Immunotherapy, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Get the latest biotech news for Cancer, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
mRNA vaccines have been used for cancer therapies as well as for protection from infectious diseases, particularly for COVID-19.| Labiotech.eu
Discover promising advancements in oncology clinical trials presented by experts and biotechs from around the globe at ASCO 2024.| Labiotech.eu
Get the latest biotech news for GPCR, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Get the latest biotech news for Antibodies, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu
Take a closer look at how the obesity drug market is currently soaring after the success of new weight loss drugs like Wegovy.| Labiotech.eu
GLP-1 agonists have been on the radar for a while to treat diabetes and obesity. And of late, there has been renewed interest in these drugs.| Labiotech.eu
Get the latest biotech news for investment, including the latest research, partnerships, regulations, and technology advancements.| Labiotech.eu